296 results on '"Young, Juan I."'
Search Results
2. Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects
3. GATAD2B-associated neurodevelopmental disorder (GAND): clinical and molecular insights into a NuRD-related disorder
4. Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2–associated schwannomas reveals differences in efficacy and drug resistance development
5. Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimer’s disease
6. Distinct sex-specific DNA methylation differences in Alzheimer’s disease
7. SORD-deficient rats develop a motor-predominant peripheral neuropathy unveiling novel pathophysiological insights.
8. Post cardiac arrest physical exercise mitigates cell death in the septal and thalamic nuclei and ameliorates contextual fear conditioning deficits in rats
9. Critical evaluation of the reliability of DNA methylation probes on the Illumina MethylationEPIC v1.0 BeadChip microarrays
10. Sord deficient rats develop a motor-predominant peripheral neuropathy unveiling novel pathophysiological insights
11. MIAMI-AD (Methylation in Aging and Methylation in AD): an integrative knowledgebase that facilitates explorations of DNA methylation across sex, aging, and Alzheimer’s disease
12. Distinct CSF biomarker‐associated DNA methylation in Alzheimer’s disease and cognitively normal subjects
13. APOE genotype vs Local ancestry: what contributes the most to Alzheimer’s disease risk?
14. Hi‐C analysis in frontal cortex using local ancestry identifies ancestry‐specific chromatin 3D interactions
15. Assessing the functional effect of the Presenilin‐1 G206A variant on age of onset of Alzheimer Disease in the Puerto Rican population
16. Genomic editing of APOE4/4 to APOE3/3 in iPSCs bearing African or European local ancestry surrounding APOE
17. Deciphering the Genomic Regulatory Architecture of iPSC Derived Oligodendrocytes from Diverse Ancestries for Alzheimer’s Disease Studies
18. Characterization of an African ancestry‐specific protective allele of the APOE ε4 allele for Alzheimer’s disease risk
19. Sex-specific DNA methylation differences in Alzheimer’s disease pathology
20. Critical evaluation of the reliability of DNA methylation probes on the Illumina MethylationEPIC BeadChip microarrays
21. C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease.
22. Resveratrol Preconditioning Induces Genomic and Metabolic Adaptations within the Long-Term Window of Cerebral Ischemic Tolerance Leading to Bioenergetic Efficiency
23. Epigenome-wide meta-analysis of DNA methylation differences in prefrontal cortex implicates the immune processes in Alzheimer’s disease
24. Critical evaluation of the reliability of DNA methylation probes on the Illumina MethylationEPIC BeadChip microarrays for dementia research
25. Transcriptional consequences of MBD5 disruption in mouse brain and CRISPR-derived neurons
26. Models to Understand Human Genomics, Final Considerations
27. List of Contributors
28. Integrative Modeling and Novel Technologies in Human Genomics
29. Use of local genetic ancestry to assess TOMM40-523′ and risk for Alzheimer disease
30. Genome-wide brain DNA methylation analysis suggests epigenetic reprogramming in Parkinson disease
31. Ancestry‐related differences in chromatin accessibility and gene expression of APOE ε4 are associated with Alzheimer's disease risk
32. Distinct CSF biomarker-associated DNA methylation in Alzheimer's disease and cognitively normal subjects
33. Post cardiac arrest physical exercise mitigates cell death in the septal and thalamic nuclei and ameliorates contextual fear conditioning deficits in rats
34. Ancestry-related differences in chromatin accessibility and gene expression ofAPOE4are associated with Alzheimer disease risk
35. Neuronal SIRT1 (Silent Information Regulator 2 Homologue 1) Regulates Glycolysis and Mediates Resveratrol-Induced Ischemic Tolerance
36. Characterization of ANKRD11 mutations in humans and mice related to KBG syndrome
37. Cross-tissue meta-analysis of blood and brain epigenome-wide association studies in Alzheimer’s disease
38. Additional file 1 of Distinct sex-specific DNA methylation differences in Alzheimer’s disease
39. MethReg: estimating the regulatory potential of DNA methylation in gene transcription
40. Identifying differential regulatory control of APOE ɛ4 on African versus European haplotypes as potential therapeutic targets
41. Isolation of the Atlantic salmon β-actin promoter and its use to drive expression in salmon cells in culture and in transgenic zebrafish
42. Converging evidence for differential regulatory control of APOEε4 on African versus European haplotypes
43. Resveratrol Preconditioning Induces a Novel Extended Window of Ischemic Tolerance in the Mouse Brain
44. SLITRK6 mutations cause myopia and deafness in humans and mice
45. Ischemic Preconditioning Alters the Epigenetic Profile of the Brain from Ischemic Intolerance to Ischemic Tolerance
46. DNA Methylation Variation Is Identified in Monozygotic Twins Discordant for Non-syndromic Cleft Lip and Palate
47. Additional file 1 of Sex-specific DNA methylation differences in Alzheimer’s disease pathology
48. Disruption of Mbd5 in mice causes neuronal functional deficits and neurobehavioral abnormalities consistent with 2q23.1 microdeletion syndrome
49. Correct developmental expression level of Rai1 in forebrain neurons is required for control of body weight, activity levels and learning and memory
50. A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer's Disease in African Ancestry.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.